The reiteration of a 'Buy' rating by a Roth MKM analyst indicates a positive outlook for Stryker's stock. The maintained price target of $345 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in stock price in the short term.